21世纪的癌症筛查与早期检测
Cancer Screening and Early Detection in the 21 Century.
作者信息
Loud Jennifer T, Murphy Jeanne
出版信息
Semin Oncol Nurs. 2017 May;33(2):121-128. doi: 10.1016/j.soncn.2017.02.002. Epub 2017 Mar 23.
Abstract
OBJECTIVE
To review the trends in and principles of cancer screening and early detection.
DATA SOURCES
Journal articles, United States Preventive Services Task Force (USPSTF) publications, professional organization position statements, and evidence-based summaries.
CONCLUSION
Cancer screening has contributed to decreasing the morbidity and mortality of cancer. Efforts to improve the selection of candidates for cancer screening, to understand the biological basis of carcinogenesis, and the development of new technologies for cancer screening will allow for improvements in cancer screening over time.
IMPLICATIONS FOR NURSING PRACTICE
Nurses are well-positioned to lead the implementation of cancer screening recommendations in the 21 century through their practice, research, educational efforts, and advocacy.
摘要
目的
回顾癌症筛查与早期检测的趋势及原则。
数据来源
期刊文章、美国预防服务工作组（USPSTF）出版物、专业组织立场声明及循证综述。
结论
癌症筛查有助于降低癌症的发病率和死亡率。随着时间的推移，努力改进癌症筛查候选者的选择、理解致癌作用的生物学基础以及开发新的癌症筛查技术，将使癌症筛查得到改善。
对护理实践的启示
护士处于有利地位，可通过其实践、研究、教育工作和宣传，在21世纪引领癌症筛查建议的实施。
相似文献
1
Cancer Screening and Early Detection in the 21 Century.
Semin Oncol Nurs. 2017 May;33(2):121-128. doi: 10.1016/j.soncn.2017.02.002. Epub 2017 Mar 23.
2
Early Detection and Screening for Breast Cancer.
Semin Oncol Nurs. 2017 May;33(2):141-155. doi: 10.1016/j.soncn.2017.02.009. Epub 2017 Mar 29.
3
Cancer Screening and Early Detection in Older People: Considerations for Nursing Practice.
Semin Oncol Nurs. 2017 May;33(2):199-207. doi: 10.1016/j.soncn.2017.02.006. Epub 2017 Mar 23.
4
Prostate Cancer Screening.
Semin Oncol Nurs. 2017 May;33(2):156-164. doi: 10.1016/j.soncn.2017.02.003. Epub 2017 Mar 23.
5
Gastrointestinal Cancers: Screening and Early Detection.
Semin Oncol Nurs. 2017 May;33(2):165-171. doi: 10.1016/j.soncn.2017.02.004. Epub 2017 Mar 23.
6
Screening and Early Detection of Lung Cancer.
Semin Oncol Nurs. 2017 May;33(2):129-140. doi: 10.1016/j.soncn.2017.03.001. Epub 2017 Apr 5.
7
Disparities in Cancer Screening Practices among Minority and Underrepresented Populations.
Semin Oncol Nurs. 2017 May;33(2):184-198. doi: 10.1016/j.soncn.2017.02.008. Epub 2017 Apr 6.
8
Risk Assessment, Prevention, and Early Detection: Challenges for the Advanced Practice Nurse.
Semin Oncol Nurs. 2015 Nov;31(4):306-26. doi: 10.1016/j.soncn.2015.08.007. Epub 2015 Aug 14.
9
Breast cancer screening in women: An integrative literature review.
J Am Acad Nurse Pract. 2010 Dec;22(12):668-73. doi: 10.1111/j.1745-7599.2010.00564.x. Epub 2010 Nov 5.
10
[Screening for melanoma, an advanced practice nurse consultation].
Rev Infirm. 2014 Dec(206):38-40.
引用本文的文献
1
Lymph nodes in MRI-based early-stage rectal cancer: can MRI accurately predict lymph node involvement?
Eur Radiol. 2025 Aug 25. doi: 10.1007/s00330-025-11945-y.
2
Emerging biomarkers for early cancer detection and diagnosis: challenges, innovations, and clinical perspectives.
Eur J Med Res. 2025 Aug 18;30(1):760. doi: 10.1186/s40001-025-03003-6.
3
Effectiveness of early cancer screening and diagnosis in urban China.
Sci Rep. 2025 Jul 2;15(1):23160. doi: 10.1038/s41598-025-05020-1.
4
Current Status of the National Cancer Screening Program in Korea: History, Achievements, and Future Directions.
J Prev Med Public Health. 2025 Jul;58(4):337-347. doi: 10.3961/jpmph.25.268. Epub 2025 Jun 21.
5
Cluster-based human-in-the-loop strategy for improving machine learning-based circulating tumor cell detection in liquid biopsy.
Patterns (N Y). 2025 May 30;6(6):101285. doi: 10.1016/j.patter.2025.101285. eCollection 2025 Jun 13.
6
Diagnostic significance of the novel biomarker combination for early-stage non-small cell lung cancer detection: results of the blind clinical study.
Front Oncol. 2025 May 19;15:1508563. doi: 10.3389/fonc.2025.1508563. eCollection 2025.
7
Incidence, Risk and Trends of Multiple Primary Cancers in Patients With Colorectal Cancer: Evidence From the South Australian Cancer Registry.
Cancer Med. 2025 Jun;14(11):e70984. doi: 10.1002/cam4.70984.
8
Overall Survival of Hungarian Cancer Patients Diagnosed Between 2011 and 2019, Based on the Health Insurance Fund Database.
Cancers (Basel). 2025 May 15;17(10):1670. doi: 10.3390/cancers17101670.
9
High-risk HPV genotypes in women with abnormal cytology: a 12-year retrospective study.
Infect Agent Cancer. 2025 May 26;20(1):34. doi: 10.1186/s13027-025-00664-0.
10
HES1 in cancer: a key player in tumorigenesis and its prognostic significance.
Mol Genet Genomics. 2025 May 20;300(1):49. doi: 10.1007/s00438-025-02259-1.
本文引用的文献
1
The effect of the USPSTF PSA screening recommendation on prostate cancer incidence patterns in the USA.
Nat Rev Urol. 2017 Jan;14(1):26-37. doi: 10.1038/nrurol.2016.251. Epub 2016 Dec 20.
2
The bimanual ovarian palpation examination in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: Performance and complications.
J Med Screen. 2017 Dec;24(4):220-222. doi: 10.1177/0969141316680381. Epub 2016 Nov 30.
3
Practice Bulletin No. 168: Cervical Cancer Screening and Prevention.
Obstet Gynecol. 2016 Oct;128(4):e111-e130. doi: 10.1097/AOG.0000000000001708.
4
Breast cancer risk prediction using a clinical risk model and polygenic risk score.
Breast Cancer Res Treat. 2016 Oct;159(3):513-25. doi: 10.1007/s10549-016-3953-2. Epub 2016 Aug 26.
5
Diagnostic Performance of Risk of Ovarian Malignancy Algorithm Against CA125 and HE4 in Connection With Ovarian Cancer: A Meta-analysis.
Int J Gynecol Cancer. 2016 Nov;26(9):1586-1593. doi: 10.1097/IGC.0000000000000804.
6
Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium.
Am J Hum Genet. 2016 Jun 2;98(6):1067-1076. doi: 10.1016/j.ajhg.2016.03.024. Epub 2016 May 12.
7
The American Cancer Society challenge goal to reduce US cancer mortality by 50% between 1990 and 2015: Results and reflections.
CA Cancer J Clin. 2016 Sep;66(5):359-69. doi: 10.3322/caac.21348. Epub 2016 May 13.
8
Population-based screening for cancer: hope and hype.
Nat Rev Clin Oncol. 2016 Sep;13(9):550-65. doi: 10.1038/nrclinonc.2016.50. Epub 2016 Apr 13.
9
Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
Lancet. 2016 Mar 5;387(10022):945-956. doi: 10.1016/S0140-6736(15)01224-6. Epub 2015 Dec 17.
10
Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer: Updated Guidelines From the European Group on Tumor Markers.
Int J Gynecol Cancer. 2016 Jan;26(1):43-51. doi: 10.1097/IGC.0000000000000586.
Zotero 插件